- Home
- MRNA vs NICE Comparison
MRNA vs NICE Comparison
Compare MRNA & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- NICE
- Stock Information
- Founded
- MRNA 2010
- NICE 1986
- Country
- MRNA United States
- NICE Israel
- Employees
- MRNA N/A
- NICE N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- NICE Computer Software: Prepackaged Software
- Sector
- MRNA Health Care
- NICE Technology
- Exchange
- MRNA Nasdaq
- NICE Nasdaq
- Market Cap
- MRNA 10.6B
- NICE 9.9B
- IPO Year
- MRNA 2018
- NICE 1996
- Fundamental
- Price
- MRNA $24.25
- NICE $164.42
- Analyst Decision
- MRNA Hold
- NICE Strong Buy
- Analyst Count
- MRNA 20
- NICE 14
- Target Price
- MRNA $51.94
- NICE $224.29
- AVG Volume (30 Days)
- MRNA 8.5M
- NICE 247.7K
- Earning Date
- MRNA 05-01-2025
- NICE 05-19-2025
- Dividend Yield
- MRNA N/A
- NICE N/A
- EPS Growth
- MRNA N/A
- NICE 32.29
- EPS
- MRNA N/A
- NICE 6.76
- Revenue
- MRNA $3,177,000,000.00
- NICE $2,735,272,000.00
- Revenue This Year
- MRNA N/A
- NICE $9.02
- Revenue Next Year
- MRNA $11.16
- NICE $7.21
- P/E Ratio
- MRNA N/A
- NICE $23.42
- Revenue Growth
- MRNA N/A
- NICE 15.05
- 52 Week Low
- MRNA $23.15
- NICE $137.19
- 52 Week High
- MRNA $170.47
- NICE $229.33
- Technical
- Relative Strength Index (RSI)
- MRNA 38.02
- NICE 64.19
- Support Level
- MRNA $23.70
- NICE $155.66
- Resistance Level
- MRNA $28.52
- NICE $160.26
- Average True Range (ATR)
- MRNA 1.36
- NICE 3.35
- MACD
- MRNA -0.09
- NICE 1.21
- Stochastic Oscillator
- MRNA 11.11
- NICE 95.91
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NICE NICE Ltd
Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice's CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.